fda drug shortages tirzepatide zepbound shortage status 2025 Lilly's weight-loss removed from FDA's list FDA says this weight loss

(1) Use MyFitnessPal to log your protein and water, keep an eye on patterns, and save a short list of go-to options for autopilot mornings

Discussion of any concerns or questions you may have

In a recent study, patients taking Semaglutide achieved an average weight loss of 15.2% over one year, while those taking Tirzepatide experienced an average weight loss of 15.7%

Lower doses might avoid common side effects seen with full-dose tirzepatide, such as nausea or gastrointestinal discomfort

Shorter studies (single dose or 1 month) have generally shown little to no effect [1][12]

Administration: The injection typically takes only a few minutes